|
 |
22 SEPTEMBER 2008
Annual General Meeting 18 September 2008
Proxy Votes Cast
| |
Votes For |
Votes Against |
Discretionary Votes |
Votes Withheld |
| Resolution 1 |
22,019,906 |
0 |
2,100 |
823,860 |
| Resolution 2 |
22,843,766 |
0 |
2,100 |
0 |
| Resolution 3 |
22,843,766 |
0 |
2,100 |
0 |
| Resolution 4 |
22,841,998 |
500 |
2,100 |
1,268 |
| Resolution 5 |
22,841,998 |
500 |
2,100 |
1,268 |
| Resolution 6 |
22,842,316 |
250 |
2,100 |
1,200 |
| Resolution 7 |
22,843,266 |
500 |
2,100 |
0 |
| Resolution 8 |
22,843,766 |
0 |
2,100 |
0 |
Notes to editors
The Company seeks to achieve substantial capital appreciation by investing in emerging growth companies through specialised US venture capital funds focused on the information technology, biotechnology and healthcare sectors.
Return to Press Release Index
|
|
|
|
|
|
|
|
